Mayo Clinic and W. L. Gore & Associates have announced a partnership to develop implantable cell therapies to treat debilitating conditions with no cure.
The for-profit company, Avobis Bio, will combine a patient’s own stem cells with bioabsorbable scaffolds to stimulate the healing of perianal fistulas, painful tunneling wounds that affect patients with Crohn’s disease. Few healing options exist, and patients endure multiple surgeries and ongoing risk of life-threatening complications, according to Mayo Clinic. A recent clinical trial of an investigational treatment has shown promising results, the healthcare system said.
Get the full story on our sister site, Drug Discovery & Development.